Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
Nenhuma Miniatura disponível
Citações na Scopus
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
AME PUBLISHING COMPANY
Autores
CHEUNG, Tan-To
LIU, Rong
CIPRIANI, Federica
WANG, Xiaoying
EFANOV, Mikhail
FUKS, David
CHOI, Gi-Hong
SYN, Nicholas L.
CHONG, Charing C. N.
BENEDETTO, Fabrizio Di
Citação
HEPATOBILIARY SURGERY AND NUTRITION, v.12, n.2, p.205-+, 2023
Resumo
Background: The use of laparoscopic (LLR) and robotic liver resections (RLR) has been safely performed in many institutions for liver tumours. A large scale international multicenter study would provide stronger evidence and insight into application of these techniques for huge liver tumours >= 10 cm. Methods: This was a retrospective review of 971 patients who underwent LLR and RLR for huge (>= 10 cm) tumors at 42 international centers between 2002-2020. Results: One hundred RLR and 699 LLR which met study criteria were included. The comparison between the 2 approaches for patients with huge tumors were performed using 1: 3 propensity- score matching (PSM) (73 vs. 219). Before PSM, LLR was associated with significantly increased frequency of previous abdominal surgery, malignant pathology, liver cirrhosis and increased median blood. After PSM, RLR and LLR was associated with no significant difference in key perioperative outcomes including media operation time (242 vs. 290 min, P=0.286), transfusion rate rate (19.2% vs. 16.9%, P=0.652), median blood loss (200 vs. 300 mL, P=0.694), open conversion rate (8.2% vs. 11.0%, P=0.519), morbidity (28.8% vs. 21.9%, P=0.221), major morbidity (4.1% vs. 9.6%, P=0.152), mortality and postoperative length of stay (6 vs. 6 days, P=0.435). Conclusions: RLR and LLR can be performed safely for selected patients with huge liver tumours with excellent outcomes. There was no significant difference in perioperative outcomes after RLR or LLR.
Palavras-chave
Laparoscopic liver resection (LLR), robotic liver resection (RLR), hepatocellular carcinoma, colorectal liver metastases, huge
Referências
- BALASEGARAM M, 1972, AUST NZ J SURG, V42, P1, DOI 10.1111/j.1445-2197.1972.tb06728.x
- Ban D, 2021, ANN SURG, V274, P1043, DOI 10.1097/SLA.0000000000003799
- Bryant R, 2009, ANN SURG, V250, P103, DOI 10.1097/SLA.0b013e3181ad6660
- Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647
- Cherqui D, 2021, ANN SURG, V273, P96, DOI 10.1097/SLA.0000000000004475
- Cheung TT, 2020, SURG ONCOL, V35, P315, DOI 10.1016/j.suronc.2020.09.012
- Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a
- Cheung TT, 2021, HEPATOBIL SURG NUTR, V10, P587, DOI 10.21037/hbsn-21-327
- Chiow AKH, 2021, BRIT J SURG, V108, P1513, DOI 10.1093/bjs/znab321
- Chong CC, 2022, JAMA SURG, V157, P436, DOI 10.1001/jamasurg.2022.0161
- Chua D, 2021, BRIT J SURG, V108, P351, DOI 10.1093/bjs/znaa118
- D'Hondt M, 2023, J ROBOT SURG, V17, P79, DOI 10.1007/s11701-022-01405-w
- Dagher I, 2008, SURG ENDOSC, V22, P372, DOI 10.1007/s00464-007-9487-2
- Dagher I, 2014, J HEPATO-BIL-PAN SCI, V21, P732, DOI 10.1002/jhbp.140
- Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
- Durán M, 2022, WORLD J HEPATOL, V14, DOI 10.4254/wjh.v14.i1.224
- Goh BK, 2021, ANN ACAD MED SINGAP, V50, P742, DOI 10.47102/annals-acadmedsg.2021213
- Goh BK, 2020, ANN ACAD MED SINGAP, V49, P742, DOI 10.47102/annals-acadmedsg.202036
- Goh BKP, 2020, ANZ J SURG, V90, P1092, DOI 10.1111/ans.15683
- Goh BKP, 2020, ANZ J SURG, V90, P553, DOI 10.1111/ans.15563
- Goh BKP, 2019, ANZ J SURG, V89, P201, DOI 10.1111/ans.14417
- Goh BKP, 2018, SURG ENDOSC, V32, P4658, DOI 10.1007/s00464-018-6310-1
- Gumbs AA, 2021, SURG ENDOSC, V35, P5268, DOI 10.1007/s00464-020-08122-1
- Halls MC, 2019, ANN SURG, V269, P221, DOI 10.1097/SLA.0000000000002996
- Kabir T, 2022, EJSO-EUR J SURG ONC, V48, P169, DOI 10.1016/j.ejso.2021.08.019
- Kabir T, 2021, SURG ONCOL, V37, DOI 10.1016/j.suronc.2021.101569
- Kawaguchi Y, 2018, ANN SURG, V267, P13, DOI 10.1097/SLA.0000000000002176
- Lee KF, 2021, SURG ENDOSC, V35, P2316, DOI 10.1007/s00464-020-07645-x
- Shelat VG, 2015, ANN SURG ONCOL, V22, P1288, DOI 10.1245/s10434-014-4107-6
- Terminology Committee of the International Hepato-Pancreato-Biliary Association, 2000, HPB, V2, P333, DOI 10.1016/S1365-182X(17)30755-4
- Wakabayashi G, 2016, HEPATOL SURG NUTR, V5, P281, DOI 10.21037/hbsn.2016.03.03
- Wakayama K, 2017, J SURG ONCOL, V115, P324, DOI 10.1002/jso.24501
- Yang HY, 2022, BRIT J SURG, V109, P311, DOI 10.1093/bjs/znab463
- Yang HY, 2021, ANN HEPATO-BIL-PANCR, V25, P8, DOI 10.14701/ahbps.2021.25.1.8
- Ziogas IA, 2021, SURG ENDOSC, V35, P524, DOI 10.1007/s00464-020-08008-2